US Kidney Cancer Therapeutics and Diagnostics Market Expected to Reach 3 Bn US$ By 2028: Ken Research The US Kidney Cancer Therapeutics and Diagnostics Market is poised for a steered growth due to rise in cases of kidney cancer, an increase in success rate of targeted therapies, expansion of hospitals and NCI- funded cancer centers, and constant growth in population. Story Outline Rising cases of Kidney Cancer due to today’s drastic lifestyle… Read More »
